Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jai Radhakrishnan

Showing results (181-190 of 225) with videos related to

Pageof 23
Sort By:
Kidney International Reports|December 23, 2017
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental GlomerulosclerosisFlavio Vincenti, Fernando C Fervenza, Kirk N Campbell, et al.
Frontiers in Medicine|January 8, 2021
Optimizing Kidney Replacement Therapy During the COVID-19 Pandemic Across a Complex Healthcare SystemJane Akomeah, Aljenica Apostol, Esteen Barnes, et al.
Kidney International Reports|May 14, 2023
IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT StudyJonathan Barratt, Brad Rovin, Muh Geot Wong, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2010
Pathologic classification of diabetic nephropathyThijs W Cohen Tervaert, Antien L Mooyaart, Kerstin Amann, et al.
Kidney International Reports|May 20, 2024
Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX StudyHoward Trachtman, Jai Radhakrishnan, Michelle N Rheault, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 27, 2018
Procurement Biopsies in the Evaluation of Deceased Donor KidneysDustin Carpenter, S Ali Husain, Corey Brennan, et al.
Journal of the American Society of Nephrology : JASN|October 27, 2018
DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGSHoward Trachtman, Peter Nelson, Sharon Adler, et al.
Kidney International|June 5, 2014
Taming the chronic kidney disease epidemic: a global view of surveillance effortsJai Radhakrishnan, Giuseppe Remuzzi, Rajiv Saran, et al.
Coronary Artery Disease|May 17, 2019
Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgeryHussein M Rahim, Erin Flattery, Fotis Gkargkoulas, et al.
Kidney International|October 6, 2018
Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allograftsDominick Santoriello, Syed A Husain, Sacha A De Serres, et al.
Pageof 23

Showing results (181-190 of 225) with videos related to

Sort By:
Pageof 23
Kidney International Reports|December 23, 2017
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental GlomerulosclerosisFlavio Vincenti, Fernando C Fervenza, Kirk N Campbell, et al.
Frontiers in Medicine|January 8, 2021
Optimizing Kidney Replacement Therapy During the COVID-19 Pandemic Across a Complex Healthcare SystemJane Akomeah, Aljenica Apostol, Esteen Barnes, et al.
Kidney International Reports|May 14, 2023
IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT StudyJonathan Barratt, Brad Rovin, Muh Geot Wong, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2010
Pathologic classification of diabetic nephropathyThijs W Cohen Tervaert, Antien L Mooyaart, Kerstin Amann, et al.
Kidney International Reports|May 20, 2024
Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX StudyHoward Trachtman, Jai Radhakrishnan, Michelle N Rheault, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 27, 2018
Procurement Biopsies in the Evaluation of Deceased Donor KidneysDustin Carpenter, S Ali Husain, Corey Brennan, et al.
Journal of the American Society of Nephrology : JASN|October 27, 2018
DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGSHoward Trachtman, Peter Nelson, Sharon Adler, et al.
Kidney International|June 5, 2014
Taming the chronic kidney disease epidemic: a global view of surveillance effortsJai Radhakrishnan, Giuseppe Remuzzi, Rajiv Saran, et al.
Coronary Artery Disease|May 17, 2019
Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgeryHussein M Rahim, Erin Flattery, Fotis Gkargkoulas, et al.
Kidney International|October 6, 2018
Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allograftsDominick Santoriello, Syed A Husain, Sacha A De Serres, et al.
Pageof 23